Open AccessMyasthenia gravis as a prognostic marker in patients with thymoma
Author(s) -
Bernardo CachoDíaz,
Karen SalmerónMoreno,
Nydia A. Lorenzana-Mendoza,
Julia Texcocano,
Óscar Arrieta
Publication year - 2018
Publication title -
journal of thoracic disease
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.682
H-Index - 60
eISSN - 2077-6624
pISSN - 2072-1439
DOI - 10.21037/jtd.2018.04.95
Subject(s) - thymoma , myasthenia gravis , medicine , thymus neoplasm , thymectomy , pathology , mediastinal mass
Thymoma is the most common mediastinal tumor, representing <1% of all cancers. It is usually associated with paraneoplastic disorders, mainly myasthenia gravis (MG). The aim of the present study was to describe patients with thymoma and the differences between those with MG and those without it.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom